DSM - proposed appointment to the Managing Board of Directors
(Thomson Reuters ONE) -
The Supervisory Board of Royal DSM is pleased to announce that it will propose
to the Annual General Meeting of Shareholders on 3 May 2013 to appoint Mr.
Dimitri de Vreeze to the Managing Board of DSM with responsibility for DSM's
Materials Sciences clusters, with effect from 1 September 2013.
Mr. de Vreeze will succeed Mr. Nico Gerardu, who will be retiring from the
company after a long and rich career in DSM. Mr. Gerardu was appointed to the
Managing Board in 2006, after holding several senior management positions and
serving as Business Group Director of DSM Fine Chemicals and later DSM Anti-
Infectives.
The members of the Supervisory Board and Mr. Gerardu's colleagues on the
Managing Board would like to express their gratitude and thanks for his
leadership throughout his long career with DSM and for his contributions to the
organization's success.
Dimitri de Vreeze (1967), a Dutch national, is at present Business Group
Director of DSM Resins. He has built a strong team while delivering real
progress in DSM Resins.
Mr. de Vreeze joined DSM in 1990 in Finance in DSM Fine Chemicals. He
subsequently moved to sales management and took on increasingly bigger roles,
including that of Global Business Manager Sizing & Binders based in Italy. In
2002 he became Business Director Composite Resins Europe, based in Switzerland.
Dimitri was Business Unit Director Coating Resins between 2005 and 2007 and
Business Unit Director NeoResins between 2007 and 2010.
Mr. de Vreeze studied Business Economics at the University of Groningen and is
Postgraduate of the Chartered Controllers Program Maastricht.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
23,500 employees deliver annual net sales of around ?9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com.
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 10 4590275
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Dimitri de Vreeze-jpg:
http://hugin.info/130663/R/1685214/552022.jpg
Press release-pdf:
http://hugin.info/130663/R/1685214/552020.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1685214]
Unternehmensinformation / Kurzprofil:
Datum: 14.03.2013 - 08:15 Uhr
Sprache: Deutsch
News-ID 239306
Anzahl Zeichen: 3823
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 101 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM - proposed appointment to the Managing Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
